Stable isotopes refer to a class of isotopes that naturally exist in living organisms and do not exhibit radioactivity. Their atomic nuclear structure is stable and does not spontaneously emit radiation, causing changes in nuclear structure. Compared with radioactive isotopes, stable isotopes do not have radioactivity, and there are no special protective requirements in the separation, labeling compound synthesis, and application processes. They are easy to operate, safe to use, and non-toxic, and can be directly used in animal and human nutrition, clinical medical research, biomedicine, drug development, nutritional metabolism, and many other fields.

Currently, stable isotopes commonly used in various fields include boron 10 (10B), boron 11 (11B), oxygen 18 (18O), and carbon 13 (13C).10B is a stable isotope of boron, with a relative atomic mass of 10.0129370, a natural atomic abundance of 19.9%, and a nuclear spin of 3+. In the nuclear industry, 10B can be used to manufacture neutron counter tubes, reactor control rods, and thermal neutron shielding materials.

11B is also a stable isotope of boron, with a relative atomic mass of 11.009306, a natural atomic abundance of 80.1%, and a nuclear spin of 3/2. 11B can be used as an additive in steel, which can greatly improve the high-temperature and radiation resistance of reactors when used in the manufacturing of reactors.

18O is a natural and stable oxygen isotope, as well as an environmental isotope, and an important precursor for the production of fluorodeoxyglucose (FDG) for positron emission tomography (PET).

13C is a naturally stable isotope of carbon, with a nucleus containing 6 protons and 7 neutrons. As an environmental isotope, it accounts for approximately 1.1% of Earth\'s natural carbon.

 

Source: www.globalmarketmonitor.com

According to our research data, the global stable isotope market revenue is expected to reach $282.39 million in 2023, among which the estimated market revenue of 18O is $59.14 million, with an estimated market share of 27.25%.

From the perspective of downstream application patterns, the medical field is the largest downstream application market for stable isotopes. Data shows that the market revenue for stable isotopes used in the medical field is expected to be $150.24 million in 2023, accounting for 53.04% of the market share.

Global Stable Isotope Market Revenue and Share by Enterprise in 2020

Source: www.globalmarketmonitor.com

From the perspective of market competition pattern, the concentration of the global stable isotope market is moderate. Data shows that the stable isotope market revenue of the top 3 enterprises in the industry reached a total of $93.92 million in 2020, accounting for 36.27% of the market. The total revenue of the top 6 enterprises was $136.74 million, with a total market share of 52.80%. The top three companies in the rankings were Cambridge Isotope Laboratories, JSC Isotope, and Center of Molecular Research. In 2020, the stable isotope market revenue of these three companies accounted for 20.65%, 8.43%, and 7.19% of the global market, respectively.

For momre information, please click: 《2023 Global Stable Isotopes Market Analysis Report, Key Competitors, Market Effect Factors, Growth, And Forecast》.